Pharmaceuticals

DeepHow's new GMP-compliant platform, PharmaCloud, uses AI to train and verify operators, tackling the long-standing conflict between innovation and regulation.

A new partnership aims to simplify access to custom-compounded drugs for weight loss and HRT, blending digital tech with specialized pharmacy services.

With booming exports and robust government backing, Italy is making a strategic play to become a global life sciences powerhouse. Here's what's driving the momentum.

Australian biopharma Immuron reports strong global sales for its travel supplement and launches a new IBS product, navigating industry mergers and digital trends.

Veteran drug discoverer Dr. Adam Davenport joins as CSO, bringing expertise in cutting-edge modalities to accelerate client pipelines in a competitive market.

Advicenne's novel therapy for distal Renal Tubular Acidosis is under FDA review, potentially bringing the first approved treatment to thousands in the U.S.

At a major San Francisco summit, Chinese biotechs unveiled breakthrough heart and cancer drugs, signaling a strategic shift from manufacturing to global innovation.

Hong Kong-based Cellyan Biotechnology has 180 days to rescue its Nasdaq listing after its stock price fell below the $1.00 minimum requirement.

Corvus Pharmaceuticals is set to unveil pivotal early data for its novel eczema drug, soquelitinib, a moment analysts call a critical milestone.

Genmab's antibody drug epcoritamab is the first of its kind to slow cancer progression in a Phase 3 trial for R/R DLBCL, offering a new path for patients.

A new North Carolina facility will use advanced Blow-Fill-Seal tech to produce essential medicines, aiming to fix supply chains and reduce US reliance on imports.

Profusa launches its Lumee system for research, aiming to capture a piece of the $47B CRO market and revolutionize drug development with real-time data.

A new partnership aims to revolutionize chronic care by letting patients self-administer large-volume biologics safely in their own homes.

In a strategic move to enhance domestic drug production, Agno Pharma has acquired a key Oregon manufacturing site, signaling major industry consolidation.

With a new $16.5M loan, Ocular Science is poised to expand its role in compounded eye medications, meeting the needs of an aging population.

Backed by Canada's life sciences engine adMare, new biotech firm Ocythera is advancing a unique non-retinoid therapy for debilitating bone disorders.

With the appointment of agency veteran Raffi Siyahian, VaultBio aims to bridge the gap between life sciences strategy and real-world market execution.

A new partnership aims to make life-saving cancer and anti-infective drugs stable at room temperature, revolutionizing global access and sustainability.

Merck's former R&D IT head Matt Studney joins TetraScience, a move highlighting biopharma's critical pivot from fragmented data to industrial-scale AI.

International Healthcare Week 2026 will unite pharma, medtech, and labs, aiming to transform healthcare for 700 million people across Southeast Asia.